Browsing Tag
Brian Hahn
2 posts
Avacta (AIM: AVCT) clears deferred bond repayments as AVA6103 milestones shape management options
Avacta has paid another £2.61 million of its convertible bond in cash, reducing principal to £12 million, days after granting management options equivalent to about 4.1% of current issued capital.
Avacta FY25 puts AVCT on a clock: £16.9m cash, two Phase 1 reads, one shot
Avacta Group posts FY25 results with two clinical assets in trial, £16.9m cash, and AVA6103 data due in H2 2026 as AVCT trades near 52-week high.